NEXGEL Announces Appointment of Miranda Toledano to Board of Directors

financial business newsImage via Pixabay

LANGHORNE, PA — NEXGEL, Inc. announced that the Company recently appointed Miranda Toledano to its Board of Directors. Ms. Toledano brings over 20 years of biotech, principal investment and capital markets experience to NEXGEL. Since its founding in 2018, Ms. Toledano served as Chief Operating Officer, Chief Financial Officer and Board member at TRIGR Therapeutics, a clinical-stage immuno-oncology biotech company, recently acquired by Compass Therapeutics.

“Miranda’s strategic, operational leadership and transactional experience, shepherding biopharma companies from early stages of clinical development to commercialization, will be invaluable to NEXGEL as we continue to develop our Hydrogel technology across differentiated healthcare, consumer and novel clinical indications,” said Adam Levy, NEXGEL CEO.

“NEXGEL has quickly emerged as a leading provider of proprietary hydrogel technology with diverse ultra-gentle, high-water-content products that are now poised to disrupt both the medical and consumer markets,” added Ms. Toledano. “The Company is currently reaching a critical value inflection point, and I look forward to working closely alongside NEXGEL’s leadership team to support its novel programs and strategic development.”

READ:  Route 663 Intersection Periodic Traffic Stop for Slope Repair in Milford Township, Bucks County

Prior to joining TRIGR, Ms. Toledano served on the executive management team at Sorrento Therapeutics where she helped drive its immuno-oncology, CAR-T and pain franchises. Ms. Toledano previously served as Head of Healthcare Investment Banking at MLV & Co. (acquired by B. Riley FBR & Co.), where she executed capital market transactions totaling over $4 billion in value. From 2004 to 2010, Miranda served as Vice President in the investment group at Royalty Pharma, where she worked on monetization transactions involving blockbuster auto-immune, oncology and infectious disease therapeutics. Earlier in her career, Ms. Toledano developed and served as Senior Manager in the life science corporate finance group at Ernst & Young Israel. Ms. Toledano is a member of the board of Compass Therapeutics, Entera Bio, Journey Medical and Lipomedix.

READ:  U.S. 1 Periodic Nighttime Lane Closures, Traffic Stoppages Next Week for Construction in Bucks County

Ms. Toledano holds a Master of Business Administration degree in Finance and Entrepreneurship from New York University’s Stern School of Business, as well as a Bachelor of Arts degree in Economics from Tufts University.

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.